Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

MIN 117

Next Previous
X
Search
Drug Profile

MIN 117

Alternative Names: MIN-117; Wf-516; WF516

Latest Information Update: 28 Feb 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Mitsubishi Tanabe Pharma Corporation
  • Developer Minerva Neurosciences
  • Class Analgesics; Antidepressants; Oxadiazoles; Piperidines; Small molecules
  • Mechanism of Action 5-HT1A serotonin receptor antagonists; Alpha 1 adrenergic receptor antagonists; Dopamine plasma membrane transport protein antagonists; Serotonin 2A receptor antagonists; Serotonin plasma membrane transport protein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Pain
  • Discontinued Major depressive disorder

Most Recent Events

  • 28 Feb 2023 No recent reports of development identified for preclinical development in Pain in USA
  • 24 Feb 2021 MIN 117 is still in phase II trials for Major depressive disorder in Bulgaria, Finland, Poland and USA (Minerva Neurosciences pipeline, February 2021)
  • 31 Dec 2020 Discontinued - Phase-II for Major depressive disorder in Latvia, Bulgaria, USA, Finland, Poland (PO)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top